JAMA cardiology最新文献

筛选
英文 中文
Advancing Equity in Cardiovascular Disease Risk Prediction. 推进心血管疾病风险预测的公平性。
IF 24 1区 医学
JAMA cardiology Pub Date : 2025-06-25 DOI: 10.1001/jamacardio.2025.1872
Nilay S Shah
{"title":"Advancing Equity in Cardiovascular Disease Risk Prediction.","authors":"Nilay S Shah","doi":"10.1001/jamacardio.2025.1872","DOIUrl":"https://doi.org/10.1001/jamacardio.2025.1872","url":null,"abstract":"","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":"34 1","pages":""},"PeriodicalIF":24.0,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144478861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Finerenone According to Frailty in Heart Failure 芬内酮对心力衰竭的影响
IF 24 1区 医学
JAMA cardiology Pub Date : 2025-06-18 DOI: 10.1001/jamacardio.2025.1775
Jawad H. Butt, Pardeep S. Jhund, Alasdair D. Henderson, Brian L. Claggett, Chern-En Chiang, Gerard C. M. Linssen, Clara I. Saldarriaga, Jose F. K. Saraiva, Naoki Sato, Morten Schou, Dirk von Lewinski, James Lay-Flurrie, Andrea Scalise, Katja Rohwedder, Akshay S. Desai, Carolyn S. P. Lam, Michele Senni, Sanjiv J. Shah, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J. V. McMurray
{"title":"Finerenone According to Frailty in Heart Failure","authors":"Jawad H. Butt, Pardeep S. Jhund, Alasdair D. Henderson, Brian L. Claggett, Chern-En Chiang, Gerard C. M. Linssen, Clara I. Saldarriaga, Jose F. K. Saraiva, Naoki Sato, Morten Schou, Dirk von Lewinski, James Lay-Flurrie, Andrea Scalise, Katja Rohwedder, Akshay S. Desai, Carolyn S. P. Lam, Michele Senni, Sanjiv J. Shah, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J. V. McMurray","doi":"10.1001/jamacardio.2025.1775","DOIUrl":"https://doi.org/10.1001/jamacardio.2025.1775","url":null,"abstract":"ImportancePatients with frailty are often perceived to have a less favorable benefit-risk profile for novel therapies and therefore may be less likely to receive these.ObjectiveTo examine the efficacy and safety of finerenone, compared with placebo, according to frailty status in patients with heart failure (HF) and mildly reduced ejection fraction (HFmrEF) or with HF and preserved ejection fraction (HFpEF).Design, Setting, and ParticipantsThis was a prespecified secondary analysis of a phase 3 randomized clinical trial, the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF), conducted across 653 sites in 37 countries. Patients with HF with New York Heart Association functional class II through IV, a left ventricular ejection fraction of 40% or higher, evidence of structural heart disease, and elevated natriuretic peptide levels were randomized between September 2020 and January 2023. Data analysis was conducted from October 1 to November 30, 2024.InterventionAddition of once-daily finerenone or placebo to usual therapy.Main Outcomes and MeasuresThe primary outcome was a composite of cardiovascular death and total worsening HF events. Frailty was measured using the Rockwood cumulative deficit approach.ResultsOf the 6001 patients randomized in FINEARTS-HF, a frailty index (FI) was calculable in 5952 patients (mean [SD] age, 72.0 [9.6] years; 3241 [54.4%] male). In total, 1588 patients (26.7%) had class I frailty (FI ≤0.210 [not frail]), 2141 (36.0%) had class II frailty (FI 0.211-0.310 [more frail]), and 2223 (37.3%) had class III frailty (FI ≥0.311 [most frail]). Compared with patients with class I frailty, those with class II and III frailty had a higher risk of the primary outcome (unadjusted rate ratio [RR], 1.88 [95% CI, 1.54-2.28] for class II and 3.86 [95% CI, 3.22-4.64] for class III). The effect of finerenone on the primary outcome did not vary significantly by frailty class (class I: RR, 1.07 [95% CI, 0.77-1.49]; class II: RR, 0.66 [95% CI, 0.52-0.83]; class III: RR, 0.91 [95% CI, 0.76-1.07]; <jats:italic>P</jats:italic> for interaction = .77). Frailty class did not modify the effects of finerenone on the components of the primary outcome, all-cause death, or improvement in the Kansas City Cardiomyopathy Questionnaire total symptom score. The effects of finerenone, compared with placebo, on experiencing hypotension, elevated creatinine level, hyperkalemia, or hypokalemia did not differ by frailty class.Conclusions and RelevanceIn FINEARTS-HF, finerenone reduced the risk of total worsening HF events and cardiovascular death, and it improved symptoms; these effects were not modified by frailty status. In addition, the effects of finerenone on experiencing hypotension, elevated creatinine level, hyperkalemia, or hypokalemia did not differ by frailty status.Trial RegistrationClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" ext-link-type=","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":"25 1","pages":""},"PeriodicalIF":24.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144320298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Last Mile in Prevention-Can Coronary CT Angiography Help? 预防的最后一公里——冠状动脉CT血管造影有帮助吗?
IF 24 1区 医学
JAMA cardiology Pub Date : 2025-06-18 DOI: 10.1001/jamacardio.2025.1772
Pamela S Douglas,Neha J Pagidipati
{"title":"The Last Mile in Prevention-Can Coronary CT Angiography Help?","authors":"Pamela S Douglas,Neha J Pagidipati","doi":"10.1001/jamacardio.2025.1772","DOIUrl":"https://doi.org/10.1001/jamacardio.2025.1772","url":null,"abstract":"","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":"89 1","pages":""},"PeriodicalIF":24.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144319808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension-Reply. 高血压患者心肌梗死风险与脑卒中风险的预测
IF 24 1区 医学
JAMA cardiology Pub Date : 2025-06-18 DOI: 10.1001/jamacardio.2025.1862
Joseph Barker,Arunashis Sau,Fu Siong Ng
{"title":"Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension-Reply.","authors":"Joseph Barker,Arunashis Sau,Fu Siong Ng","doi":"10.1001/jamacardio.2025.1862","DOIUrl":"https://doi.org/10.1001/jamacardio.2025.1862","url":null,"abstract":"","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":"240 1","pages":""},"PeriodicalIF":24.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144319809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy CT血管造影、健康生活方式行为和预防治疗
IF 24 1区 医学
JAMA cardiology Pub Date : 2025-06-18 DOI: 10.1001/jamacardio.2025.1763
Michael McDermott, Phyo H. Khaing, Mohammed N. Meah, Kang-Ling Wang, Neil Craig, Krithika Loganath, Craig Balmforth, Edwin J. R. van Beek, John Norrie, Brian McKinstry, Bruce Guthrie, Lewis Ritchie, Dorien M. Kimenai, Nicholas L. Mills, Marc R. Dweck, Michelle C. Williams, David E. Newby
{"title":"CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy","authors":"Michael McDermott, Phyo H. Khaing, Mohammed N. Meah, Kang-Ling Wang, Neil Craig, Krithika Loganath, Craig Balmforth, Edwin J. R. van Beek, John Norrie, Brian McKinstry, Bruce Guthrie, Lewis Ritchie, Dorien M. Kimenai, Nicholas L. Mills, Marc R. Dweck, Michelle C. Williams, David E. Newby","doi":"10.1001/jamacardio.2025.1763","DOIUrl":"https://doi.org/10.1001/jamacardio.2025.1763","url":null,"abstract":"ImportanceHealthy lifestyles and uptake of primary preventive therapies for cardiovascular disease remain poor.ObjectiveTo determine the impact of coronary computed tomography (CT) angiography on healthy lifestyle behaviors, acceptance of recommended treatments, and modification of risk factors as compared with guideline-directed cardiovascular risk scoring.Design, Setting, and ParticipantsThis was a nested substudy conducted from September 2020 to August 2024 of a randomized clinical trial where participants underwent cardiovascular risk scoring or coronary CT angiography. Primary care–based screening took place in Scotland. Included in the analysis were asymptomatic individuals aged 40 to 70 years without known cardiovascular disease and with at least 1 cardiovascular risk factor. Study data were analyzed from August to September 2024.InterventionsAll participants received lifestyle advice with additional recommendations for moderate-intensity statin therapy if the 10-year cardiovascular risk was greater than or equal to 10% or combined antiplatelet and at least moderate-intensity statin therapies if coronary atherosclerosis was identified on CT angiography.Main Outcomes and MeasuresThe composite primary outcome was compliance with the National Institute for Health and Care Excellence recommendations for diet, body mass index, smoking, and physical exercise at 6 months.ResultsBetween September 2020 and January 2024, 400 participants were enrolled (median [IQR] age, 62 [56-65] years; 198 female [49.5%]; median [IQR] 10-year cardiovascular risk, 14% [9%-19%]) with 195 randomized to cardiovascular risk scoring and 205 to coronary CT angiography. At 6 months, those who underwent CT angiography were more likely to meet the primary composite end point (17% [33 of 194 participants] vs 6% [10 of 177 participants]; odds ratio, 3.42; 95% CI, 1.63-6.94; <jats:italic>P</jats:italic> < .001). Compared with cardiovascular risk scoring, fewer participants were recommended preventive therapy after CT angiography (51% [105 of 205 participants] vs 75% [147 of 195 participants]; <jats:italic>P</jats:italic> < .001), but acceptance of recommendations was higher (77% [81 of 105 participants] vs 46% [68 of 147 participants]; <jats:italic>P</jats:italic> < .001). This resulted in similar use of lipid-lowering therapy (44% [90 of 205 participants] vs 35% [69 of 195 participants]; OR, 1.43; 95% CI, 0.96-2.15; <jats:italic>P</jats:italic> = .08) and greater use of antiplatelet therapy in those randomized to CT angiography (40% [83 of 205 participants] vs 0.5% [1 of 195 participants]; <jats:italic>P</jats:italic> < .001). Participants randomized to coronary CT angiography had small incremental improvements in risk factors and 10-year cardiovascular risk, largely driven by those with CT-defined coronary atheroma.Conclusions and RelevanceResults of this cohort study reveal that compared with cardiovascular risk scoring, coronary ","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":"12 1","pages":""},"PeriodicalIF":24.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144319814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Error in Additional Contributions. 额外贡献错误。
IF 14.8 1区 医学
JAMA cardiology Pub Date : 2025-06-18 DOI: 10.1001/jamacardio.2025.2039
{"title":"Error in Additional Contributions.","authors":"","doi":"10.1001/jamacardio.2025.2039","DOIUrl":"10.1001/jamacardio.2025.2039","url":null,"abstract":"","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":" ","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12177720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144325730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension. 高血压患者心肌梗死风险与脑卒中风险的预测
IF 24 1区 医学
JAMA cardiology Pub Date : 2025-06-18 DOI: 10.1001/jamacardio.2025.1859
Franz H Messerli
{"title":"Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension.","authors":"Franz H Messerli","doi":"10.1001/jamacardio.2025.1859","DOIUrl":"https://doi.org/10.1001/jamacardio.2025.1859","url":null,"abstract":"","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":"3 1","pages":""},"PeriodicalIF":24.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144319819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension. 高血压患者心肌梗死风险与脑卒中风险的预测
IF 24 1区 医学
JAMA cardiology Pub Date : 2025-06-18 DOI: 10.1001/jamacardio.2025.1856
Salah Al-Zaiti,Leo Anthony Celi,Peter Macfarlane
{"title":"Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension.","authors":"Salah Al-Zaiti,Leo Anthony Celi,Peter Macfarlane","doi":"10.1001/jamacardio.2025.1856","DOIUrl":"https://doi.org/10.1001/jamacardio.2025.1856","url":null,"abstract":"","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":"240 1","pages":""},"PeriodicalIF":24.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144320296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Patient With Cough, Palpitations, Dyspnea, and Chest Pain. 有咳嗽、心悸、呼吸困难及胸痛的病人。
IF 14.8 1区 医学
JAMA cardiology Pub Date : 2025-06-11 DOI: 10.1001/jamacardio.2025.1671
Yingying Wang, Yuchen Wang, Xuhong Geng
{"title":"A Patient With Cough, Palpitations, Dyspnea, and Chest Pain.","authors":"Yingying Wang, Yuchen Wang, Xuhong Geng","doi":"10.1001/jamacardio.2025.1671","DOIUrl":"https://doi.org/10.1001/jamacardio.2025.1671","url":null,"abstract":"","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":" ","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Still Racing Against the Clock-Persistent Delays in STEMI Care. 仍在与时间赛跑——STEMI护理的持续延误。
IF 14.8 1区 医学
JAMA cardiology Pub Date : 2025-06-11 DOI: 10.1001/jamacardio.2025.1423
Roxana Mehran
{"title":"Still Racing Against the Clock-Persistent Delays in STEMI Care.","authors":"Roxana Mehran","doi":"10.1001/jamacardio.2025.1423","DOIUrl":"https://doi.org/10.1001/jamacardio.2025.1423","url":null,"abstract":"","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":" ","pages":""},"PeriodicalIF":14.8,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信